21 January 2020
Congratulations to Dr Simona Valletta and Dr Sarah Gooding, who were selected for the Translational Research Training in Hematology Program, a year-long training and mentoring experience by the American Society of Hematology and the European Hematology Association.
13 January 2020
Congratulations to Prof Jacobsen, who was elected member of the Academy's Class for Medical Sciences.
12 September 2019
Many congratulations to Dr Simona Valletta, a postdoctoral research in MRC MHU, who was awarded an Intermediate Research Fellowship from the Kay Kendall Leukaemia Fund.
2 July 2019
Medical Sciences Division is delighted to welcome Dr Anjan Thakurta to Oxford, having now taken up his position of Visiting Professor of Cancer, Biology and Translational Science within the Radcliffe Department of Medicine.
12 February 2019
Analysing tumours cell by cell will help develop personalised cancer treatments.
23 November 2018
Deutsche Bank employees across the UK raised this generous sum via their ‘One Day’ initiative, in collaboration with Cure Leukaemia
7 August 2018
Congratulations to Professor Leanne Hodson (Professor of Metabolic Physiology), Professor Adam Mead (Professor of Haematology) Professor Gary Ford (Professor of Stroke Medicine) and Professor Damian Tyler (Professor of Physiological Metabolism) who were all awarded the title of full professor in the recent Recognition of Distinction.
9 January 2018
The Radcliffe Department of Medicine has launched a new initiative – the Oxford Centre for Haematology (OCH). Through this virtual Centre we aim to promote integration between academic and clinical haematology programmes in the University and Oxford University Hospital NHS Foundation Trust and thereby capitalise on scientific opportunities to transform our understanding of haemopoiesis and blood diseases.
5 January 2018
Congratulations to Prof Jackie Boultwood and Dr Andrea Pellagatti, who have been awarded a project grant from Leuka – a leading leukaemia research charity. Their work will focus on Chronic myelomonocytic leukaemia (CMML), a blood cancer with a poor prognosis and limited treatment options.
29 September 2017
Members of the Oxford and Thames Valley MDS Patient Support Group, which provides support to those affected by Myelodysplastic Syndromes, visited the MRC Weatherall Institute of Molecular Medicine (WIMM) on Friday 29 September. The visit was hosted by Dr Lynn Quek and members of Prof Paresh Vyas' research team at the MRC Molecular Hematology Unit, who are members of the Radcliffe Department of Medicine. Their research is supported by the NIHR Oxford Biomedical Research Centre.
21 September 2017
New research shows that blood donors could safely give blood more frequently than is allowed at present. At the moment in the UK men can give blood every 12 weeks, women every 16 weeks. The new research demonstrates that in certain situations and for certain donors, shortening the donation interval is a viable approach for blood services to take.